RASSF1A, BLU, NORE1A, PTEN and MGMT Expression and Promoter Methylation in Gliomas and Glioma Cell Lines and Evidence of Deregulated Expression of De Novo DNMTs

Overview

Journal Brain Pathol

Date 2008 Jul 12

PMID 18616639

Citations 27

Authors

Aiala Lorente

Wolf Mueller

Edurne Urdangarin

Paula Lazcoz

Ulrike Lass

Andreas von Deimling

Javier S Castresana

Affiliations

Soon will be listed here.

Abstract

Methylation of CpG islands in gene promoters can lead to gene silencing. Together with deletion or mutation, it may cause a loss of function of tumor suppressor genes. RASSF1A (3p21.3), NORE1A (1q32.1) and BLU (3p21.3) have been shown to be downregulated by methylation in cancer, and PTEN (10q23.3) and MGMT (10q26.1) are located in areas commonly deleted in astrocytomas. MGMT methylation predicts a better response and a longer overall survival in patients with glioblastomas treated with temozolomide. We analyzed 53 astrocytoma samples and 10 high-grade glioma cell lines. Gene expression was assessed by RT-PCR. Bisulfite sequencing, MSP and a melting curve analysis-based real-time PCR were performed to detect promoter methylation. Treatments with 5'-aza-2'-deoxicitidine were applied to restore gene expression in cell lines. Ninety-two percent of tumor samples were methylated for RASSF1A, 30%-57% for BLU and 47% for MGMT, suggesting promoter methylation of these genes to be a common event in glioma tumorigenesis. Only 4% of the tumors revealed a methylated promoter for NORE1A. No association between methylation and loss of expression could be established for PTEN. We identified de novo DNMTs overexpression in a subset of tumors which may explain the methylation phenotype of individual gliomas.

Citing Articles

Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.

Williams O, Hu L, Huang W, Patel P, Bartom E, Bei L J Biol Chem. 2023; 299(7):104867.

PMID: 37247756 PMC: 10404618. DOI: 10.1016/j.jbc.2023.104867.

MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation.

Bondarev N, Ivanenko K, Khabusheva E, Lebedev T, Manukhov I, Prassolov V Int J Mol Sci. 2022; 23(21).

PMID: 36361596 PMC: 9657631. DOI: 10.3390/ijms232112807.

Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.

Hegde M, Joshi M J Cancer Res Clin Oncol. 2021; 147(4):937-971.

PMID: 33604794 PMC: 7954751. DOI: 10.1007/s00432-021-03519-4.

Ras signaling through RASSF proteins.

Donninger H, Schmidt M, Mezzanotte J, Barnoud T, Clark G Semin Cell Dev Biol. 2016; 58:86-95.

PMID: 27288568 PMC: 5034565. DOI: 10.1016/j.semcdb.2016.06.007.

Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression.

Wan Abdul Rahman W, Ab Rahman K, Nafi S, Hashairi Fauzi M, Jaafar H Int J Clin Exp Pathol. 2015; 8(6):6095-106.

PMID: 26261487 PMC: 4525821.

References

Jones P, Takai D . The role of DNA methylation in mammalian epigenetics. Science. 2001; 293(5532):1068-70. DOI: 10.1126/science.1063852. View

Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

Lin R, Hsu H, Chang J, Chen C, Chen J, Wang Y . Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer. 2006; 55(2):205-13. DOI: 10.1016/j.lungcan.2006.10.022. View

Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A . Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Brain Pathol. 2007; 17(1):5-10. PMC: 8095625. DOI: 10.1111/j.1750-3639.2006.00030.x. View

Ullrich S, Mercer W, Appella E . Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. Oncogene. 1992; 7(8):1635-43. View

Belinsky S, Nikula K, Baylin S, Issa J . Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci U S A. 1996; 93(9):4045-50. PMC: 39484. DOI: 10.1073/pnas.93.9.4045. View

Wistuba I, Behrens C, Virmani A, Mele G, Milchgrub S, Girard L . High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000; 60(7):1949-60. View

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

Hesson L, Bieche I, Krex D, Criniere E, Hoang-Xuan K, Maher E . Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene. 2004; 23(13):2408-19. DOI: 10.1038/sj.onc.1207407. View

10.

Lorente A, Mueller W, Urdangarin E, Lazcoz P, von Deimling A, Castresana J . Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer. 2008; 8:61. PMC: 2266933. DOI: 10.1186/1471-2407-8-61. View

11.

Hesson L, Dallol A, Minna J, Maher E, Latif F . NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene. 2003; 22(6):947-54. DOI: 10.1038/sj.onc.1206191. View

12.

Fanelli M, Caprodossi S, Ricci-Vitiani L, Porcellini A, Tomassoni-Ardori F, Amatori S . Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene. 2007; 27(3):358-65. DOI: 10.1038/sj.onc.1210642. View

13.

Fan X, Munoz J, Sanko S, Castresana J . PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas. Int J Oncol. 2002; 21(3):667-74. View

14.

Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M . Long-term survival with glioblastoma multiforme. Brain. 2007; 130(Pt 10):2596-606. DOI: 10.1093/brain/awm204. View

15.

Issa J, Vertino P, Wu J, Sazawal S, Celano P, Nelkin B . Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst. 1993; 85(15):1235-40. DOI: 10.1093/jnci/85.15.1235. View

16.

Wiencke J, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamguney T . Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007; 9(3):271-9. PMC: 1907411. DOI: 10.1215/15228517-2007-003. View

17.

El-Deiry W, Nelkin B, Celano P, Yen R, Falco J, Hamilton S . High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A. 1991; 88(8):3470-4. PMC: 51469. DOI: 10.1073/pnas.88.8.3470. View

18.

Esteller M, Corn P, Baylin S, Herman J . A gene hypermethylation profile of human cancer. Cancer Res. 2001; 61(8):3225-9. View

19.

Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman J, Esteller M . Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol. 2006; 83(1):91-3. DOI: 10.1007/s11060-006-9292-0. View

20.

Horiguchi K, Tomizawa Y, Tosaka M, Ishiuchi S, Kurihara H, Mori M . Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene. 2003; 22(49):7862-5. DOI: 10.1038/sj.onc.1207082. View